Live Breaking News & Updates on Cerebral Palsy Caused

Stay updated with breaking news from Cerebral palsy caused. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Birth weight and head circumference predict IQ and motor performance at 4 years of age

Bochum's medics have discovered a simple method to predict IQ and neurologic performance at 4 years preschool age. They prospectively screened 5,301 infants by cranial ultrasound and extrapolated the results of a previous study from the same center in which both cranial ultrasound and psychomotor development (Intelligence quotient (IQ), Maze test (MT), and Neurologic examination (NOS)) were measured. ....

United States , Holmerb White , Gerd Neuh , Arne Jensen , Ann Pediatr , Gynecology International , University Bochum , Hg Association , Campus Clinic Gynecology , Ruhr University Bochum , Gynecology Global , Matter Damage , Born Infants Is Determined , Head Circumference , Missing Link , Cord Blood Therapy , Infantile Cerebral Palsy , From Bench , Obstet Gynecol Int , Autologous Cord Blood Therapy , Pediatric Ischemic Stroke , Cerebral Palsy Caused , Cephalic Molding , Individual Treatment , Case Reports ,

Investment breakthrough for BrainRepair UG start-up – Stem cell treatment for newborns

One of the most successful inventors and entrepreneurs who masterminded the unprecedented success of Qiagen. ....

Nordrhein Westfalen , Thierry Bernard , Metin Colpan , Arne Jensen , European Patent Office , World Health Organization , European Commission , European Medicines Agency , Frankfurt Stock Exchange , University Bochum , Ruhr University Bochum , Advisory Board , Nasdaq First North , Orphan Drug Designation , European Medicines , Prime Standard , Chief Executive , Orphan Medicinal Product Designation , European Inventor Award , Autologous Cord Blood Therapy , Pediatric Ischemic Stroke , Cerebral Palsy Caused , Cephalic Molding , Individual Treatment , Case Reports , னோற்ர்ேன் வெஸ்ட்ஃபாலன் ,

Investment breakthrough for BrainRepair UG start-up - Stem cell treatment for newborns

Investment breakthrough for BrainRepair UG start-up - Stem cell treatment for newborns
Media
Links
Dr. Metin Colpan, founder of Nasdaq listed Qiagen N.V. acquired 5% of BrainRepair UG shares worth EUR 15M
One of the most successful inventors and entrepreneurs who masterminded the unprecedented success of Qiagen N.V. from a start-up to a 10 billion market cap enterprise has taken the decision to refocus his activities on BrainRepair UG, a spin-off of the Ruhr-University Bochum (RUB). BrainRepair UG has developed a unique method based on own (autologous) cord blood stem cells to treat brain damage and cerebral palsy (CP) in newborns affecting 70,000 babies in the EU each year. Metin Colpan’s patented invention has become a standard method recommended by the World Health Organization (WHO) and is used by researchers all over the world, changing the way they can access, purify and understand genetic data in DNA and RNA. The European Patent Office states “The tire ....

Nordrhein Westfalen , Thierry Bernard , Metin Colpan , Arne Jensen , European Patent Office , World Health Organization , European Commission , European Medicines Agency , Frankfurt Stock Exchange , University Bochum , Ruhr University Bochum , Advisory Board , Nasdaq First North , Orphan Drug Designation , European Medicines , Prime Standard , Chief Executive , Orphan Medicinal Product Designation , European Inventor Award , Cord Blood Therapy , Infantile Cerebral Palsy , From Bench , Obstet Gynecol Int , Autologous Cord Blood Therapy , Pediatric Ischemic Stroke , Cerebral Palsy Caused ,